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The Value of Defibrillator
Electrograms for Recognition of
Clinical Ventricular Tachycardias and for Pace
Mapping of Post-Infarction Ventricular Tachycardia
Kentaro Yoshida, MD,* Tzu-Yu Liu, MS,† Clayton Scott, PHD,† Alfred Hero, PHD,†
Miki Yokokawa, MD,* Sanjaya Gupta, MD,* Eric Good, DO,* Fred Morady, MD,* Frank Bogun, MD*
Ann Arbor, Michigan
Objectives The purpose of this study was to assess the value of implantable cardioverter-defibrillator (ICD) electrograms
(EGMs) in identifying clinically documented ventricular tachycardias (VTs).
Background Twelve-lead electrocardiograms (ECG) of spontaneous VT often are not available in patients referred for catheter
ablation of post-infarction VT. Many of these patients have ICDs, and the ability of ICD EGMs to identify a specific
configuration of VT has not been described.
Methods In 21 consecutive patients referred for catheter ablation of post-infarction VT, 124 VTs (mean cycle length: 393 
103 ms) were induced, and ICD EGMs were recorded during VT. Clinical VT had been documented with 12-lead ECGs
in 15 of 21 patients. The 12-lead ECGs of the clinical VTs were compared with 64 different inducible VTs (mean cycle
length: 390  91 ms) to assess how well the ICD EGMs differentiated the clinical VTs from the other induced VTs. The
exit site of 62 VTs (mean cycle length: 408  112 ms) was identified by pace mapping (10 to 12 of 12 matching
leads). The spatial resolution of pace mapping to identify a VT exit site was determined for both the 12-lead ECGs and
the ICD EGMs using a customized MATLAB program (version 7.5, The MathWorks, Inc., Natick, Massachusetts).
Results Analysis of stored EGMs by comparison of receiver-operating characteristic curve cutoff values accurately distin-
guished the clinical VTs from 98% of the other inducible VTs. The mean spatial resolution of a 12-lead ECG pace
map for the VT exit site was 2.9  4.0 cm2 (range 0 to 17.5 cm2) compared with 8.9  9.0 cm2 (range 0 to 35
cm2) for ICD EGM pace maps. The spatial resolution of pace mapping varied greatly between patients and be-
tween VTs. The spatial resolution of ICD EGMs was 1.0 cm2 for 1 of the target VTs in 12 of 21 patients and
19 of 62 VTs. By visual inspection of the ICD EGMs, 96% of the clinical VTs were accurately differentiated from
previously undocumented VTs.
Conclusions Stored ICD EGMs usually are an accurate surrogate for 12-lead ECGs for differentiating clinical VTs from other
VTs. Pace mapping based on ICD EGMs has variable resolution but may be useful for identifying a VT exit
site. (J Am Coll Cardiol 2010;56:969–79) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.04.043h
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Patients who receive frequent appropriate shocks from
mplantable cardioverter-defibrillators (ICDs) often are re-
erred for catheter ablation of ventricular tachycardia (VT).
tored ICD electrograms (EGMs) of spontaneously occur-
ing VTs often are the only documentation of VT in
atients undergoing VT ablation. Multiple configurations
f VT typically are inducible in these patients. No studies
rom the *Division of Cardiovascular Medicine, University of Michigan, Ann Arbor,
ichigan; and the †Department of Electrical Engineering and Computer Science,
niversity of Michigan, Ann Arbor, Michigan. Dr. Bogun has a patent pending for the
echnique described in this report. All other authors have reported that they have no
elationships to disclose. Dr. Yoshida and Ms. Liu contributed equally to this work.m
Manuscript received November 11, 2009; revised manuscript received March 31,
010, accepted April 6, 2010.ave assessed the value of ICD EGMs as a surrogate for
2-lead electrocardiograms (ECGs) to differentiate clinical
Ts from previously undocumented VTs. The purpose of
his study was to assess the value of ICD EGMs for
ifferentiating clinical VT from other VT configurations
hat are as yet documented. In addition, the spatial resolu-
ion of pace mapping of post-infarction VT on the basis of
he 12-lead ECG and an ICD EGM were compared.
See page 980
ethods
atient characteristics. Twenty-one patients (2 women;
ean age 70  10 years; mean ejection fraction 0.25 
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Pace Mapping and ICDs September 14, 2010:969–790.13) with post-infarction VT and
implanted ICDs were referred for
catheter ablation of VT. All pa-
tients had histories of myocardial
infarction (anterior in 9 patients,
inferior in 12 patients). Before ab-
lation, all patients had failed to
respond to antiarrhythmic drug
treatment. Ten of the 21 patients
were being treated with amioda-
rone at the time of ablation, 3
patients were being treated with
mexiletine, 3 patients with meto-
prolol, 2 patients with dofetilide, 1
patient with sotalol, 1 patient with
procainamide, and 1 patient with
idocaine. Six of the patients were treated with a combination
f amiodarone and mexiletine. All patients experienced fre-
uent ICD discharges before ablation. At least 1 clinical VT
as documented with a 12-lead ECG (GE Marquette MAC
000 or 5500, GE Medical Systems, Milwaukee, Wisconsin)
n 15 of 21 patients. In the remaining 6 patients, 7-lead
elemetry recordings were available for at least 1 VT.
lectrophysiologic study, mapping, and ablation. The
tudy protocol was approved by the institutional review
oard at the University of Michigan. After informed con-
ent was obtained, a multipolar electrode catheter was
nserted into a femoral vein and positioned in the right
entricular apex. A 7-F multipolar catheter was placed at the
is bundle position. Programmed ventricular stimulation
as performed from 2 right ventricular sites using up to 4
xtrastimuli (1). After ablation, the entire stimulation pro-
ocol (with up to 4 extrastimuli) was repeated at the same 2
ites. Before ablation, a total of 124 distinct monomorphic
Ts (mean cycle length 393  103 ms; 47 left bundle
ranch block configuration and 77 right bundle branch
lock configuration) were induced in the 21 patients.
In all patients, a single spontaneous VT was recorded on
12-lead ECG (n  15) or on a 7-lead telemetry recording
n  6) before the ablation procedure. Only the spontane-
us VTs for which 12-lead ECGs were available were
efined as clinical VTs. The configuration of the clinical VT
as compared with that of the induced VT. A match was
equired in all 12 leads for the induced VT to be considered
dentical to the clinical VT. All VTs for which critical sites
ould be identified were targeted for radiofrequency
blation.
An electroanatomical mapping system (CARTO, Bio-
ense Webster, Inc., Diamond Bar, California) was used in
ll patients, with an 8-F mapping and ablation catheter with
3.5-mm irrigated-tip electrode and a 2-mm ring electrode
eparated by 1 mm (ThermoCool, Biosense Webster, Inc.).
ntracardiac EGMs were filtered at 50 to 500 Hz. The
ntracardiac EGMs and leads V1, I, II, and III were
isplayed on an oscilloscope and recorded at a speed of 100
Abbreviations
and Acronyms
CC  correlation
coefficient
ECG  electrocardiogram
EGM  electrogram
ICD  implantable
cardioverter-defibrillator
RMSd  root mean square
difference
ROC  receiver-operating
characteristic
VT  ventricular
tachycardiam/s. The recordings were stored on optical disc (EP Med pystems, Inc., West Berlin, New Jersey). Systemic hepa-
inization was maintained throughout the procedure.
Left ventricular access was obtained using a retrograde
ortic approach. A left ventricular endocardial voltage map
as constructed during sinus rhythm. Pace mapping was
erformed at low-voltage sites. Sites were considered
istinct if they were separated by 5 mm. Low voltage
as defined as a bipolar voltage 1.5 mV. Dense scar was
efined as a voltage 0.5 mV. The low-voltage area was
easured and correlated with the number of pace map-
ing sites. The sampling density was defined as the
umber of points per square centimeter of low-voltage
issue where pace mapping was performed. Sites sur-
ounding dense scar with voltage of 0.5 to 1.5 mV were
efined as border zones (2). Bipolar pace mapping was
erformed at 10 mA and a pulse width of 2 ms. If no
apture occurred, the pacing output was increased pro-
ressively to 20 mA.
Radiofrequency energy was delivered as previously de-
cribed (3). In brief, the power of radiofrequency energy was
itrated to achieve an impedance drop of 10. The maximal
emperature was 45°C. Radiofrequency energy was delivered
t isthmus sites or at VT exit sites. At exit sites, radiofre-
uency energy was delivered at sites with matching pace
aps for 60 to 120 seconds and/or until the capture
hreshold after ablation was 10 to 20 mA. Additional
esions were created at adjacent sites with matching pace
aps.
CD manufacturers and ICD EGMs. The ICDs were
rom the following manufacturers: Medtronic, Inc. (Min-
eapolis, Minnesota) (n  10); Boston Scientific Corpora-
ion (Natick, Massachusetts) (n  9); and St. Jude Medical,
nc. (St. Paul, Minnesota) (n  2). A can-to-coil configu-
ation was chosen for the far-field EGM when possible
Medtronic and St. Jude Medical devices). The far-field and
ear-field EGMs both were analyzed for spatial resolution
nd for discriminatory value. The ICD EGM with the best
patial resolution was reported.
etermination of cutoff values on the basis of receiver-
perating characteristic (ROC) curves. For comparison
f clinical VTs (including the corresponding ICD EGMs)
ith other induced VTs and for comparison of pace maps
including the corresponding ICD EGMs) with the
onfiguration of the targeted VTs, ROC curves were
onstructed. To do this, the real-time ICD EGM record-
ngs during the induced VTs and during pace mapping
ere slaved from the ICD programmer into the electro-
hysiologic recording system (EP Med Systems, Inc.).
he filter setting was adjusted between 0.05 and 300 Hz
o obtain the closest match with the real-time analog
CD signals.
For data analysis, the ICD EGMs along with the
orresponding 12-lead ECGs of the VTs and pace maps
ere exported and analyzed with a customized MATLAB
ersion 7.5 (The MathWorks, Inc., Natick, Massachusetts)
rogram in a manner described previously (4). In brief, the
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September 14, 2010:969–79 Pace Mapping and ICDs2-lead ECG complexes of each VT (Fig. 1) and the
orresponding far-field and near-field ICD EGMs were
sed as template signals against which pace maps were
ompared (test signals) (Figs. 1 and 2). The correlation
oefficient (CC) and the root mean square difference
Figure 1 Targeted VT and Pace Mapping at Exit Site
(Left) The 12-lead electrocardiogram (ECG) of a clinical ventricular tachycardia (VT
cardioverter-defibrillator (ICD) electrograms (EGMs) (ICD 1) and the far-field ICD EG
EGMs below. (Middle) The aligned test and template signals of the targeted VT an
correlation coefficient was 0.983, and the root mean square difference was 19.5.
Figure 2 Targeted VT and Pace Mapping Distant From Exit Site
(Left) The 12-lead electrocardiogram (ECG) of a targeted ventricular tachycardia (V
12-lead pace map at a site that was at a distance of 30 mm from the VT exit site
ping site (shown in Fig. 3). The correlation coefficient was 0.442 and the root mea
50.6 for the ICD electrograms, respectively.RMSd) between the template and test signals were
alculated. This was done for each ECG lead and for the
ar-field and near-field ICD EGMs. The CC and RMSd
ere then averaged for the 12 ECG leads to obtain a
ingle value.
was targeted for ablation (template signals). Below are the near-field implantable
D 2). (Right) A 12-lead pace map (test signals) at the VT exit site, with the ICD
pace map at the exit site for the 12-lead ECG tracings and the ICD EGMs. The
ng with the implantable cardioverter-defibrillator (ICD) electrograms. (Right) A
le) The aligned test and template signals of the targeted VT and the pace map-
are difference was 56.3 for the 12-lead ECG, and these values were 0.864 and) that
Ms (IC
d theT), alo
. (Midd
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Pace Mapping and ICDs September 14, 2010:969–79Two observers independently compared the 12-lead
CG pace maps post hoc and determined whether at least
0 of 12 leads matched with the targeted VT. Discrepancies
ere resolved by consensus. All pace mapping sites classified
s matching during the procedure were confirmed to be
atching in this post hoc analysis.
Pace maps were classified in a binary fashion as positive
10 of 12 matching leads) or negative (10 matching
eads). With positive pace maps, the CC between the VT
nd the pace map is expected to be high, and the RMSd
s expected to be low. Using the CC and RMSd statistics,
e varied the discrimination thresholds and determined
he ROC curve. The highest value of the sum of
ensitivity and specificity was chosen as the cutoff value
or classifying the pace maps in matching and nonmatch-
ng pace maps.
patial resolution. This cutoff value was subsequently used
o determine the spatial resolution. The spatial resolution of
ace mapping was defined as the endocardial area encom-
assing sites with matching pace maps. This area was
easured on the electroanatomical map and encompassed
he pacing sites with CCs that were equal to or higher than
he cutoff CC value and represented the spatial resolution
or pace mapping an exit site (Fig. 3). The spatial resolution
as arbitrarily defined as 0 cm2 if there was a single site with
matching pace map. An exit site was defined as a site
here the pace map matched the targeted VT and where
he stimulus-QRS interval was 30% of the VT cycle
ength when pacing was performed during sinus rhythm.
he distance of each pace mapping point from the VT exit
ite was measured on the electroanatomical map (Fig. 3),
nd this was correlated with the CC of the pace map from
ach site.
Far- and near-field ICD EGMs were analyzed in the
ame fashion as the 12-lead ECGs for assessment of the
patial resolution of the ICD EGMs.
To assess for beat-to-beat variability, between individual
RS configurations within a train of pace maps, we compared
paced QRS complexes with respect to the CC. The mean
Cs between the comparisons were 0.98  0.03 for 12-lead
CGs, 0.99  0.02 for the far-field EGMs, and 0.97  0.09
or the near-field EGMs. There were no significant differences
n pairwise comparisons between the groups.
he discriminatory value of the ICDEGMs to differentiate
linical VT from other VTs. After the clinical VT was
dentified on the basis of comparison of ECGs, the ICD
GMs recorded during the clinical VT (template signal)
ere compared with the ICD EGMs (test signal) of all
nducible VTs (Fig. 4).
To objectively compare the ICD EGMs of the clinical
T with ICD EGMs of other VTs, an ROC curve was
onstructed with the ICD EGM of the clinical VT as the
emplate signal (Fig. 5), comparing it with other ICD
GMs on the basis of EGMs of nonmatching pace maps.
cutoff value was thereby determined. Then the CC of theCD EGMs recorded during induced VTs that were pre- uiously undocumented was compared with the template
CD EGMs of the clinical VT. If the CC was lower than
he cutoff CC value of the template ROC curve, the ICD
GMs of the VT were considered different from the clinical
T (Fig. 4). The VT cycle lengths of the induced and
linical VTs also were compared.
To assess the accuracy of visual inspection, the real-time
CD EGMs of the induced VTs were compared with the
tored ICD EGMs of the clinical VTs. Two observers
eviewed the EGMs to distinguish clinical VTs from the
reviously undocumented VTs. Differences between the 2
bservers were resolved by consensus.
ollow-up. All patients were seen every 3 to 6 months in
n ICD device clinic. Treatment with amiodarone was
iscontinued in 2 patients, and mexiletine was discontinued
n 5 patients. Treatment with other antiarrhythmic medi-
ations was continued after the procedure.
tatistical analysis. Continuous variables are expressed as
ean  SD and were compared using Student t test.
iscrete variables were compared using the Fisher exact test
r by chi-square analysis as appropriate. Paired t tests were
Figure 3 A Voltage Map in a Patient With
Prior Inferolateral Myocardial Infarction
Shown is the inferolateral wall of the left ventricle (LV) with the apex and the
mitral valve annulus (MVA). The low-voltage area covered 105 cm2, and pace
mapping was performed from 62 sites, resulting in a sampling density of
0.61/cm2. The exit site (red asterisk) and the sites with matching 12-lead
pace maps are indicated in blue. The correlation coefficient cut-off value on the
basis of receiver-operating characteristic curve analysis was 0.965. The blue
circle surrounds all the points with correlation coefficients equal to or higher
than the cutoff value for this particular ventricular tachycardia (VT). The area
contained within the blue line is 1.4 cm2, which was considered the spatial
resolution of pace mapping for this particular VT. The spatial resolution of pace
mapping based on implantable cardioverter-defibrillator electrograms is shown
within the olive-colored tags and the olive line. The area contained in the olive
line is 3.6 cm2. The pace mapping site illustrated in Figure 2 is indicated by an
arrow and a white asterisk.sed to compare near- and far-field ICD recordings. One-
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September 14, 2010:969–79 Pace Mapping and ICDsay analysis of variance was used to compare the means of
ultiple samples. Spearman’s rank correlation was per-
ormed to correlate the spatial resolution of pace mapping
ith the distance to normal-voltage areas (Fig. 6). VT data
re used throughout the report as the unit of analysis. The
nalytic method we chose assumed that the data from the
Ts were independent from each other. ROC curves were
onstructed for the CC and the RMSd using the classifica-
ion by observers of matching and nonmatching pace maps
s the gold standard. Cohen’s kappa value was determined
o compare agreement between the observers comparing
s induced in the electrophysiology laboratory. Below are the near-field
rams (ICD 2). (Right) A previously undocumented VT that was induced in the electro-
est and template signals of the clinical VT compared with an induced VT of uncertain
s 44.9 for ICD 1, and these values were 0.844 and 32.1 for ICD 2, respectively.
Figure 6 Correlation Between Spatial Resolution
and Distance From Normal Tissue
The correlation between spatial resolution (y-axis in square centimeters) of the
pace map on the basis of the 12-lead electrocardiogram and the distance from
normal-voltage (1.5 mV) tissue (x-axis in millimeters).Figure 4 Clinical VT and Other Induced VT
(Left) The 12-lead electrocardiogram of a clinical ventricular tachycardia (VT) that wa
implantable cardioverter-defibrillator (ICD) electrograms (ICD 1) and the far-field ICD electrog
physiology laboratory. The corresponding ICD recordings are shown below. (Middle) The aligned t
clinical relevance. The correlation coefficient was 0.443 and the root mean square difference waFigure 5
The ROC Curves for the Clinical VTs Based on the
12-Lead ECG Pace Maps (Test Signals) That Were
Compared With the Clinical VTs (Template Signals)
The receiver-operating characteristic (ROC) curve of the 12-lead electrocardio-
gram (ECG) is shown as the black dashed line. The cutoff value for differentiat-
ing a matching pace map from a nonmatching pace map is 0.935. The ROC
curves of the implantable cardioverter-defibrillator (ICD) electrograms (EGMs)
are shown as green (far-field, ICD 2) and red (near-field, ICD 1) dashed lines.
The cutoff values of these ROC curves are 0.965 and 0.977, respectively.
When the ICD EGMs of the induced ventricular tachycardia (VT) of uncertain
clinical relevance (Fig. 4) were compared with the ICD EGMs of the clinical VTs,
the correlation coefficient was 0.443 for ICD 1 and 0.844 for ICD 2 EGMs.
Because both correlation coefficients were lower than the cutoff value of the
ROC curve of the template VT, this VT was considered different from the clini-
cal VT on the basis of the ICD EGMs.
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Pace Mapping and ICDs September 14, 2010:969–79patial Resolution of Pace Mapping for 12-Lead ECG and Far-Field ICD SignalsTable 1 Spatial Resolution of Pace Mapping for 12-Lead ECG and Far-Field ICD Signals
Patient #
(ICD Manufacturer) VT #
Cutoff Value for CC of
12-Lead ECG
Spatial Resolution of
12-Lead ECG (cm2)
Cutoff Value for CC
of ICD EGMs
Spatial Resolution of
ICD EGMs (cm2)
1 (Medtronic) VT 1 0.894 9.1 0.915 31.3
VT 3 0.944 1.4 0.918 1.4
2 (Boston Scientific) VT 1 0.987 0 0.998 0
VT 2 0.685 16.8 0.825 20.6
VT 3 0.625 8.9 0.954 0
3 (Medtronic) VT 1 0.836 1.4 0.987 1.4
VT 2 0.932 0 0.998 0
VT 3 0.921 9.6 0.963 19.4
4 (Medtronic) VT 2 0.861 7.9 0.987 11.3
VT 3 0.920 0 0.939 8.9
VT 4 0.877 6.1 0.889 10.2
5 (Boston Scientific) VT 1 0.835 9.2 0.972 15.9
VT 4 0.867 7.3 0.923 7.4
VT 7 0.893 5.4 0.929 8.3
6 (Medtronic) VT 3 0.933 0 0.990 0
VT 4 0.864 12.8 0.986 18.5
VT 5 0.915 7.3 0.970 9.3
VT 6 0.984 0 0.964 15.1
VT 7 0.898 10.3 0.851 36.5
7 (Medtronic) VT 1 0.765 0 0.988 0.1
VT 2 0.867 0.2 0.953 0.7
VT 3 0.920 0.6 0.971 12.6
8 (St. Jude Medical) VT 3 0.954 11.9 0.989 11.9
VT 4 0.962 0 0.987 10.2
VT 5 0.933 0.3 0.968 4.6
VT 7 0.905 9.0 0.831 15.6
VT 8 0.977 0.1 0.920 20.1
9 (Boston Scientific) VT 2 0.944 0 0.992 0
10 (Boston Scientific) VT 3 0.902 4.1 0.971 4.1
VT 4 0.890 4.2 0.803 33.2
11 (Medtronic) VT 2 0.897 0 0.994 0
VT 5 0.910 5.2 0.979 12.8
VT 6 0.853 4.6 0.983 12.1
VT 10 0.901 2.8 0.991 7.6
12 (St. Jude Medical) VT 4 0.871 3.5 0.973 0.1
VT 7 0.808 0 0.969 14.6
VT 9 0.875 0.1 0.923 5.3
13 (Medtronic) VT 1 0.908 1.8 0.945 1.8
VT 4 0.935 1.4 0.965 3.6
VT 5 0.961 0 0.996 0
14 (Boston Scientific) VT 3 0.939 2.0 0.914 5.6
VT 4 0.820 5.0 0.969 5.3
VT 8 0.949 4.1 0.986 6.4
15 (Boston Scientific) VT 1 0.931 6.9 0.994 6.9
VT 4 0.829 0 0.979 0.1
VT 6 0.663 7.9 0.952 10
16 (Boston Scientific) VT 2 0.960 0.1 0.992 7.9
17 (Boston Scientific) VT 1 0.832 10.4 0.978 17.5
VT 3 0.960 0.1 0.991 8.5
VT 5 0.833 17.5 0.945 22.7
VT 7 0.942 1.8 0.984 6.8
VT 8 0.894 1.0 0.968 33
18 (Medtronic) VT 1 0.986 0.1 0.983 0.1
VT 3 0.949 4.6 0.944 26.2
VT 5 0.968 0 0.956 0.1Continued on next page
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September 14, 2010:969–79 Pace Mapping and ICDsCD EGMs. Pairwise comparisons of the CC were per-
ormed when assessing the beat-to-beat variability of 3
aced beats. A p value 0.05 was considered significant.
esults
apping and ablation. A total of 124 VTs were induced
y programmed stimulation. In 13 of 15 patients in whom
he clinical VTs were documented on 12-lead ECGs, VTs
ith matching configurations were inducible by pro-
rammed stimulation. In 2 of 15 patients, the documented
Ts could not be induced; however, there were frequent
remature ventricular contractions during the procedure
hat matched the clinical VT on the basis of 12-lead ECGs.
Pace mapping was performed at 1,296 sites (a mean of 62
ites per patient, resulting in a sampling density of 0.75
oints/cm2 within low-voltage tissue) within low-voltage
reas, and 62 distinct exit sites were identified. Matching
ace maps were identified for an additional 15 VTs, but
hese were not considered exit sites because they had long
timulus-QRS intervals when pacing was performed during
inus rhythm. VT ablation sites were identified by entrain-
ent mapping in 9 VTs and by pace mapping for 68 VTs.
The mean procedure time was 383  97 min. The total
mount of radiofrequency energy delivered was 72  41 min.
After ablation, 10 VTs (8%) remained inducible. None of
he clinical VTs remained inducible. Fourteen patients
67%) had no inducible VTs after ablation. Outcomes were
o different if the exit site was identified on the basis of 10,
1, or 12 matching leads in the pace maps.
T exit sites and scar. The VT exit sites were located
ithin low-voltage areas and had a mean bipolar voltage of
ontinuedTable 1 Continued
Patient #
(ICD Manufacturer) VT #
Cutoff Value for CC of
12-Lead ECG
19 (Medtronic) VT 1 0.868
VT 2 0.868
20 (Boston Scientific) VT 1 0.864
VT 4 0.934
21 (Medtronic) VT 2 0.905
VT 5 0.986
VT 7 0.933
eported spatial resolution data for the 12-lead ECGs are based on the CC, and reported spatial r
CC  correlation coefficient; ECG  electrocardiogram; EGM  electrogram; ICD  implantable
omparison of Far- and Near-Field ICD EGMs foretermination of Spatial Resolution ofac Mapp ng
Table 2
Comparison of Far- and Near-Field ICD EGMs for
Determination of Spatial Resolution of
Pace Mapping
Variable Far-Field EGM Near-Field EGM p Value
ROC cutoff value CC 0.949 0.057 0.906 0.093 0.006
ROC cutoff value RMSd 47.5 41.8 51.8 34.1 0.73
Spatial resolution (cm2) for CC 10.1 10.0 19.6 16.4 0.0001
Spatial resolution (cm2) for RMSd 10.2 10.5 19.0 15.4 0.0001MSd root mean square difference; ROC receiver-operating characteristic; other abbreviations
s in Table 1.
J.44 0.43 mV. They were located a mean of 16 10 mm
range 4 to 46 mm) from sites with normal voltage (1.5
V). The total mean low-voltage area was 82  35 cm2
bipolar voltage1.5 mV) and 68 31 cm2 (bipolar voltage
1.0 mV).
patial resolution of pace mapping in scar using the
2-lead ECG. The spatial resolution of pace mapping for
dentifying the exit site of a VT was 3.8  4.5 cm2 (range
to 17.5 cm2) for the CC and 3.6  4.5 cm2 (range 0 to
8.3 cm2) for the RMSd (Table 1). When combined, the
patial resolution was 2.9  4.0 cm2. The spatial resolution
or 10 or 11 of 12 matching pace maps was 2.6  3.7 cm2
nd for 12 of 12 pace maps was 3.4  4.3 cm2; this was not
tatistically different (p  0.44). The distance between the
xit site and the site where the pace map was obtained was
nversely related to the CC (rs  0.51, p  0.0001) and
irectly related to the RMSd (rs  0.51, p  0.0001). The
patial resolution for the exit site was 1 cm2 in 32 of 62
apped VTs (52%). The spatial resolution correlated in-
ersely with the distance from normal voltage tissue (rs 
0.35, p  0.006) (Fig. 6). The spatial resolution of pace
apping was better in dense scar than in the border zone
2.9  3.5 cm2 vs. 6.1  5.3 cm2, p  0.03).
ial Resolution of
ead ECG (cm2)
Cutoff Value for CC
of ICD EGMs
Spatial Resolution of
ICD EGMs (cm2)
3.0 0.970 10
0 0.829 35
5.6 0.964 23.9
0 0.951 0.1
0.5 0.728 12.6
0 0.997 0
0.3 0.979 0.1
n data for the ICD EGMs are based on the CC of the far-field EGMs.
verter-defibrillator; VT  ventricular tachycardia.
omparison of ICD EGMs by ManufacturerTable 3 Comparison of ICD EGMs by Manufacturer
Variable Medtronic
Boston
Scientific
St. Jude
Medical
p
Value
Spatial resolution of
far-field EGM for
CC (cm2)
9.7 10.8 10.6 10.1 10.3 6.6 NS
Spatial resolution of
far-field EGM for
RMS (cm2)
11.7 11.6 7.6 8.7 10.9 10.7 NS
Spatial resolution of
near-field EGM
for CC (cm2)
16.8 16.0 22.2 17.4 23.0 14.7 NS
Spatial resolution of
near-field EGM
for RMS (cm2)
17.2 14.5 19.6 16.7 25.5 14.7 NS
Discrimination of
clinical VT from
other VTs
35/36 (97%) 12/12 (100%) 16/16 (100%) NS
he p values compare data obtained from Medtronic versus Boston Scientific, Medtronic versus St.Spat
12-Lude Medical, and Boston Scientific versus St. Jude Medical devices.
Abbreviations as in Tables 1 and 2.
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Patient #
Clinical VT
(Spontaneous VT/Induced VT Cycle Length [ms])
ROC Cutoff Value for Clinical VT
(ICD EGM)
Compared VTs
(Cycle Length [ms])
CC of Clinical VT
vs. Other VTs
1 VT 1 (430/500) 0.915 VT 2 (260)
VT 3 (570)
0.235
0.219
2 NA NA NA NA
3 VT 2 (540/660) 0.998 VT 1 (485) 0.536
VT 3 (470) 0.855
4 VT 4 (430/350) 0.889 VT 1 (490) 0.686
VT 2 (360) 0.544
VT 3 (390) 0.943
VT 5 (385) 0.784
5 VT 1 (470/640) 0.972 VT 2 (330) 0.873
VT 3 (270) 0.424
VT 4 (370) 0.463
VT 5 (360) 0.178
VT 6 (315) 0.835
VT 7 (670) 0.826
6 VT 3 (350/350) 0.990 VT 1 (330) 0.398
VT 2 (345) 0.803
VT 4 (315) 0.782
VT 5 (380) 0.857
VT 6 (560) 0.939
VT 7 (445) 0.561
VT 8 (485) 0.409
7 Noninducible (330/NA) NA NA NA
8 NA NA NA NA
9 VT 2 (330/210) 0.992 VT 1 (280) 0.961
VT 3 (280) 0.972
VT 4 (340) 0.856
10 Noninducible (420/NA) NA NA NA
11 VT 10 (400/485) 0.991 VT 1 (365) 0.984
VT 2 (310) 0.887
VT 3 (320) 0.104
VT 4 (325) 0.935
VT 5 (315) 0.841
VT 6 (370) 0.973
VT 7 (345) 0.867
VT 8 (450) 0.896
VT 9 (410) 0.176
12 VT 7 (310/300) 0.969 VT 1 (315) 0.861
VT 2 (360) 0.259
VT 3 (370) 0.280
VT 4 (315) 0.822
VT 5 (310) 0.937
VT 6 (275) 0.111
VT 8 (445) 0.923
VT 9 (415) 0.286
VT 10 (390) 0.067
13 NA NA NA NA
14 NA NA NA NA
15 VT 1 (500/530) 0.994 VT 2 (360) 0.975
VT 3 (390) 0.971
VT 4 (350) 0.952
VT 5 (505) 0.989
VT 6 (400) 0.960
16 NA NA NA NAContinued on next page
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September 14, 2010:969–79 Pace Mapping and ICDspatial resolution of ICD EGMs within scar. Using far-
eld ICD EGMs, the spatial resolution of pace mapping for
dentifying the exit site of a VT was 10.1 10.0 cm2 (range
to 36.5 cm2) for the CC and 10.2  10.5 cm2 (range 0 to
5 cm2) for the RMSd (Table 2). When near-field and
ar-field data were combined, the spatial resolution im-
roved to 8.9  9.0 cm2. The spatial resolution of pace
apping with ICD EGMs was 1 cm2 for 19 of 62 of the
apped VTs (31%). The spatial resolution of the 12-lead
CGs correlated with the spatial resolution of the ICD
GMs (rs  0.54, p  0.0001). The far-field ICD EGMs
t 81% of the exit sites displayed equal or better spatial
esolution for pace mapping (indicating higher accuracy) than
he near-field EGMs (Table 2). The ICD brand did not affect
he spatial resolution of the ICD EGMs (Table 3).
To assess whether there were determinants of the spatial
esolution of the ICD EGMs, they were grouped in 3
ategories of spatial resolution 3.0 cm2 (n  18), 3.0 to
10 cm2 (n  19), and 10.0 cm2 (n  25). None of the
nalyzed parameters, infarct location (anterior vs. inferior,
asal vs. apical), pace mapping score (12 of 12 vs. 10 or 11
f 12 matches), or bundle branch block, was associated with
ny of the categories.
iscriminatory role of ICD EGMs. The clinical VTs were
nducible in 13 of the 15 patients with 12-lead documen-
ation of spontaneous VT (Table 4). In 2 of 15 patients, the
linical VTs were not inducible, but frequent premature
entricular contractions with identical configurations were
resent. The template signals of the clinically documented
Ts were compared with a total of 64 test signals of VTs
hat were induced during programmed stimulation (Table 4).
ontinuedTable 4 Continued
Patient #
Clinical VT
(Spontaneous VT/Induced VT Cycle Length [ms])
RO
17 VT 1 (540/575)
18 NA
19 VT 1 (520/570)
20 VT 1 (295/395)
21 VT 5 (620/510)
he VT cycle length is indicated in bold if the comparison VT has a cycle length that is within 10%
NA  not applicable; other abbreviations as in Tables 1 and 2.he ICD EGMs were almost as accurate as the 12-lead VCGs for differentiating the clinical VT from previously
ndocumented VTs. All clinical VTs were accurately iden-
ified on the basis of the 12-lead ECG of the clinical VT,
hereas 63 of 64 VTs (98%) were correctly distinguished
rom the clinical VT on the basis of computerized analysis
f the ICD EGMs. In 8 of 13 patients (67%) in whom the
linical VT was induced, the cycle length of the clinical VT
as within 10% of the cycle length of at least 1 other
nduced VT that was not previously documented. Further-
ore, the induced clinical VT differed by 50 ms from the
reviously documented VT in 8 of 13 patients in whom the
linical VT could be induced. A mean of 1.4  1.8 induced
Ts per patient overlapped in cycle length with the clinical
Ts. The cycle length of the clinically documented VTs was
33 98 ms, compared with the cycle length of the induced
linical VT, which was 459  138 ms (p  0.3). The mean
f the absolute difference in cycle length between the
ocumented VT and the induced clinical VT was 75  49
s (range 0 to 170 ms) (Table 4).
The ICD EGMs of the clinical VTs and the previously
ndocumented VTs were compared by visual inspection
including the ICD EGMs of the noninducible patients
ho had premature ventricular contractions with identical
onfigurations to the clinical VTs). By visual inspection of
he ICD EGMs, 96% of the clinical VTs were accurately
ifferentiated from the 64 previously undocumented VTs.
he kappa value of the 2 readers for agreement of the
ompared EGMs was 0.83.
ollow-up. During a mean follow-up time of 10  5
onths, 1 of the 21 patients had recurrent VT and required
nother ablation procedure. The other patients did not have
off Value for Clinical VT
(ICD EGM)
Compared VTs
(Cycle Length [ms])
CC of Clinical VT
vs. Other VTs
0.978 VT 2 (360) 0.442
VT 3 (390) 0.156
VT 4 (350) 0.664
VT 5 (505) 0.892
VT 6 (400) 0.749
VT 7 (360) 0.798
VT 8 (400) 0.908
NA NA NA
0.970 VT 2 (460) 0.968
0.964 VT 2 (340) 0.843
VT 3 (325) 0.525
VT 4 (220) 0.336
0.997 VT 1 (470) 0.974
VT 2 (450) 0.437
VT 3 (340) 0.362
VT 4 (330) 0.987
VT 6 (770) 0.282
VT 7 (420) 0.982
clinical VT cycle length.C CutT on the basis of their ICD interrogations.
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hen ECG documentation of clinical VTs is not available
n patients with ICDs, the ICD EGMs can be used to
iscriminate the clinical VTs from other VTs that are
nduced in post-infarction patients. Furthermore, ICD
GMs may be helpful for pace mapping when a clinical VT
s not inducible during a mapping procedure.
CD EGMs and the clinical VT. Identification of clini-
ally relevant VTs in post-infarction patients undergoing
T ablation is difficult unless a 12-lead ECG of the VT is
vailable. The VT cycle lengths of induced VTs that have
ot been previously documented frequently overlap with the
T cycle length of the clinical VT, making the VT rate less
eliable as a differentiating criterion. Identification of the
linical VT is important because this may be the only VT
equiring therapy. Furthermore, a particular VT may re-
pond to antitachycardia pacing, and the identification of a
articular VT on the basis of ICD EGMs might allow
ntitachycardia pacing for that VT, thereby avoiding un-
ecessary ICD discharges. This study demonstrates that
CD EGMs are capable of identifying an induced VT as
aving occurred clinically. This can be accomplished in the
lectrophysiology laboratory by simple visual inspection
ithout offline computerized analysis.
patial resolution of pace mapping for identifying a VT
xit site. The spatial resolution of pace mapping using
2-lead ECGs in patients without structural heart disease is
pproximately 1.8 cm2, or smaller than the size of a dime
about 2.5 cm2). In this study, the spatial resolution within
ost-infarction scar was approximately double that size.
his region of interest constitutes 5% of the total endo-
ardial scar area. In most patients, the spatial resolution of
ace mapping was 1.0 cm2 for at least 1 VT.
The area with matching pace maps varied greatly from
atient to patient and within a given patient from 1 VT to
nother. More sites were ablated for VTs in which the
patial resolution was poor. The closer the exit site was to
ormal tissue, the lower the spatial resolution (i.e., the area
f a matching pace map for an exit site within a border zone
as larger than for exit sites within dense scar tissue).
herefore, an ablation strategy that targets the border zone
s likely to require more ablation than a strategy targeting
ites within scar.
The large variability in spatial resolution of pace
apping within scar is most likely due to tissue hetero-
eneity and the variable presence of surviving myocardial
undles.
CD EGMs and the identification of the VT exit site.
he spatial resolution of the 12-lead ECG to identify the
xit site of a VT with pace mapping within scar tissue is
pproximately the size of a penny (about 2.83 cm2). The
patial resolution of pace mapping using the ICD EGM is
ot as good and is larger than a silver dollar (about 5.8 cm2).
f note is that ICD EGMs are generated by a single lead in phich the vector may be combined with that of the ICD
enerator, depending on the ICD manufacturer. When
acing was performed within the exit site of a VT, the ICD
GM was always identical to the ICD EGM recorded
uring the clinical VT. In most of the patients, the spatial
esolution of the ICD EGM was excellent (1.0 cm2) for at
east 1 VT. Therefore, the ICD EGM can be used for pace
apping of a clinical VT that has been recorded by an ICD
ut not with an ECG. A major limitation of the ICD
GMs, however, is that the spatial resolution is lower than
he spatial resolution of the 12-lead ECG for identifying a
T exit site. Despite this limitation, ICD EGMs can be
seful for identifying a VT exit site. The value of ICD
GMs in targeting noninducible VTs remains to be
etermined.
tudy limitations. ICD EGMs from different manufactur-
rs were analyzed. This was not a homogeneous patient
opulation, and the results need to be confirmed in a larger
tudy. Although the ICD EGMs of 98% of previously
ndocumented VTs were accurately distinguished from
he clinical VTs by computerized analysis, if multiple
linical VTs are present and their VT exit sites are in
lose proximity, ICD EGMs might not accurately differ-
ntiate between these VTs. Another limitation is that the
nfluence of body position on ICD EGMs was not
ssessed in this study.
The pulse strength required for capture might affect the
CD EGMs. A retrograde P-wave also could affect the
2-lead configuration of the targeted VTs. Pace mapping
as used to target most of the VTs, and there is a
iscrepancy between the total number of targeted VTs and
he number of sites with matching pace maps. Yet the
ajority of VTs were no longer inducible after ablation.
imilar results were found in a prior study (3). A possible
xplanation is shared VT circuits (5). A final limitation is
hat the sampling density for pace mapping was a mean of
.75 points/cm2. A higher sampling density might have
mproved accuracy data.
linical implications. In post-infarction patients with
T, ICD EGMs can be used to differentiate clinical VTs
rom inducible VTs of uncertain clinical relevance. Al-
hough the spatial resolution of pace mapping based on
CD EGMs is inferior to the spatial resolution of 12-lead
CGs, they may be useful for determining whether an
blation catheter is located at a VT exit site. In this study,
he value of ICD EGMs as a surrogate for 12-lead ECGs
as demonstrated in a quantitative fashion by offline com-
uterized analysis. However, simple visual analysis of the
CD EGMs was found to be as accurate as computerized
nalysis for differentiating clinical VTs from previously
ndocumented VTs. Therefore, during mapping of VTs in
he electrophysiology laboratory, visual comparisons of
tored and real-time ICD EGMs provides a simple and
ractical technique for identifying clinical VTs.
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